86 related articles for article (PubMed ID: 20800033)
1. [Detection of renin in chromophobe renal cell carcinomas].
Arias LF; Bruneval P; Blanco J
Actas Urol Esp; 2010 Sep; 34(8):694-8. PubMed ID: 20800033
[TBL] [Abstract][Full Text] [Related]
2. Renin expression in adult renal epithelial tumors with granular cells.
Arias LF; Bruneval P; Blanco J
Pathol Res Pract; 2010 Nov; 206(11):731-4. PubMed ID: 20619546
[TBL] [Abstract][Full Text] [Related]
3. Pax-2 expression in adult renal tumors.
Daniel L; Lechevallier E; Giorgi R; Sichez H; Zattara-Cannoni H; Figarella-Branger D; Coulange C
Hum Pathol; 2001 Mar; 32(3):282-7. PubMed ID: 11274636
[TBL] [Abstract][Full Text] [Related]
4. Image analysis of proliferating cell nuclear antigen expression and immunohistochemical profiles in renal cell carcinoma associated with acquired cystic kidney disease: comparison with classic renal cell carcinoma.
Khurana KK; Truong LD; Verani RR
Mod Pathol; 1998 Apr; 11(4):339-46. PubMed ID: 9578084
[TBL] [Abstract][Full Text] [Related]
5. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
6. Synchronous chromophobe and papillary renal cell carcinoma. First report and review of the pathogenesis theories.
Tyritzis SI; Alexandrou PT; Migdalis V; Koritsiadis G; Anastasiou I
Pathol Int; 2009 Mar; 59(3):193-6. PubMed ID: 19261099
[TBL] [Abstract][Full Text] [Related]
7. Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma.
Xu H; He L; Feng X; Kapoor A; Tang D
Cancer Invest; 2009 Oct; 27(8):836-43. PubMed ID: 19557578
[TBL] [Abstract][Full Text] [Related]
8. Chromophobe renal cell carcinoma: a report of two cases.
Fukushima T; Nagashima Y; Nakatani Y; Nakamura N; Fukasawa K; Satomi Y; Yu K; Miyagi Y; Aoki I; Misugi K
Pathol Int; 1994 May; 44(5):401-6. PubMed ID: 7519106
[TBL] [Abstract][Full Text] [Related]
9. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
10. Renal cell neoplasms of oncocytosis have distinct morphologic, immunohistochemical, and cytogenetic profiles.
Gobbo S; Eble JN; Delahunt B; Grignon DJ; Samaratunga H; Martignoni G; Zhang S; Wang M; Brunelli M; Cossu-Rocca P; Cheng L
Am J Surg Pathol; 2010 May; 34(5):620-6. PubMed ID: 20305535
[TBL] [Abstract][Full Text] [Related]
11. [Carcinoma of the kidney with production of renin. A special form of hypertension].
Steffens J; Girardot P; Bock R; Braedel HU; Alloussi S; Ziegler M
Ann Urol (Paris); 1992; 26(1):5-9. PubMed ID: 1558374
[TBL] [Abstract][Full Text] [Related]
12. Metastatic chromophobe renal cell carcinoma in pleural fluid cytology: review of literature and report of a case.
Davion S; Rohan S; Nayar R; Kulesza P
Diagn Cytopathol; 2012 Sep; 40(9):826-9. PubMed ID: 21472872
[TBL] [Abstract][Full Text] [Related]
13. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications.
Ozcan A; Shen SS; Zhai QJ; Truong LD
Am J Clin Pathol; 2007 Aug; 128(2):245-54. PubMed ID: 17638658
[TBL] [Abstract][Full Text] [Related]
14. [E-cadherin expression and histopathological features in renal cell carcinomas].
Jin TX; Kakehi Y; Moroi S; Yoshida O
Hinyokika Kiyo; 1995 Sep; 41(9):653-7. PubMed ID: 7484527
[TBL] [Abstract][Full Text] [Related]
15. Parvalbumin is constantly expressed in chromophobe renal carcinoma.
Martignoni G; Pea M; Chilosi M; Brunelli M; Scarpa A; Colato C; Tardanico R; Zamboni G; Bonetti F
Mod Pathol; 2001 Aug; 14(8):760-7. PubMed ID: 11504835
[TBL] [Abstract][Full Text] [Related]
16. FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival.
Ramp U; Caliskan E; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
J Pathol; 2002 Apr; 196(4):430-6. PubMed ID: 11920739
[TBL] [Abstract][Full Text] [Related]
17. [Pathological correlation of dynamic magnetic resonance findings for chromophobe cell renal carcinoma].
Lu R; Li M; Zhou JJ; Zhou KR; Gu HM
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(39):2759-62. PubMed ID: 21162912
[TBL] [Abstract][Full Text] [Related]
18. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.
Delahunt B; Eble JN
Mod Pathol; 1997 Jun; 10(6):537-44. PubMed ID: 9195569
[TBL] [Abstract][Full Text] [Related]
19. [Proliferating cell nuclear antigen expression as a prognostic indicator for renal cell carcinoma: comparison with pathologic features and DNA content].
Nakano S; Kawamura J
Hinyokika Kiyo; 1995 May; 41(5):343-8. PubMed ID: 7598033
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD9/motility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas.
Kuroda N; Inoue K; Guo L; Miyazaki E; Hayashi Y; Naruse K; Toi M; Hiroi M; Shuin T; Enzan H
Hum Pathol; 2001 Oct; 32(10):1071-7. PubMed ID: 11679941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
